tiprankstipranks

Filip Dubovsky Insider Profile

4 Followers
Filip Dubovsky, President, R&D at Novavax, holds 66.61K shares in Novavax (Ticker: NVAX).
tipranks
Filip Dubovsky

Filip Dubovsky
Novavax (NVAX)
President, R&D

Not Ranked
Filip Dubovsky has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$328K
100.00%
A breakdown of Filip Dubovsky's holdings

Insider Roles

Novavax
(NVAX)
President, R&D
Roles that Filip Dubovsky holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Filip Dubovsky

Filip Dubovsky's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Novavax
Mar 12, 2024
President, R&D
Uninformative Buy
14.15K
$328.40K
Filip Dubovsky has not reported any informative transactions for NVAX, therefore, performance cannot be measured.
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Mar 11, 2024
Uninformative Buy
$52.69K
-
$0.00
Mar 12, 2024
Uninformative Buy
$14.15K
-
$0.00
Jun 21, 2023
Uninformative Sell
$16.14K
-
$0.00
Sep 19, 2023
Uninformative Sell
$47.09K
-
$0.00
Nov 07, 2023
Uninformative Sell
$4.78K
-
$0.00
List of latest transactions for each holding click on a transaction to see Filip Dubovsky's performance on stock

Filip Dubovsky insider profile FAQ

What is the percentage of profitable transactions made by Filip Dubovsky?
The percentage of profitable transactions made by Filip Dubovsky is ―.
    What is the average return per transaction made by Filip Dubovsky?
    The average return per transaction made by Filip Dubovsky is ―.
      What stocks does Filip Dubovsky hold?
      Filip Dubovsky holds: NVAX stocks.
        What was Filip Dubovsky’s latest transaction?
        Filip Dubovsky latest transaction was an Uninformative Buy of $14.15K.
          What was Filip Dubovsky's most profitable transaction?
          Filip Dubovsky’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Filip Dubovsky's role in Novavax?
            Filip Dubovsky's role in Novavax is President, R&D.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.